The catalytic cysteine of islet antigen 2 is crucial to autoantibody binding in type 1 diabetes

被引：0
|
作者：
Elvers, K. T. [1 ]
Broadhurst, J. W. [1 ]
Easton, P. R. [1 ]
Lampasona, V. [2 ]
Bingley, P. J. [1 ]
Williams, A. J. K. [1 ]
机构：
[1] Univ Bristol, Bristol BS8 1TH, Avon, England
[2] Ctr Genom Bioinformat & Biostat, Milan, Italy
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
431
引用
收藏
页码：S178 / S179
页数：2
相关论文
共 50 条
  • [1] The Core Cysteines, (C909) of Islet Antigen-2 and (C945) of Islet Antigen-2β, Are Crucial to Autoantibody Binding in Type 1 Diabetes
    Elvers, Karen T.
    Geoghegan, Ivey
    Shoemark, Debbie K.
    Lampasona, Vito
    Bingley, Polly J.
    Williams, Alistair J. K.
    [J]. DIABETES, 2013, 62 (01) : 214 - 222
  • [2] Autoantibody response to islet transplantation in type 1 diabetes
    Bosi, E
    Braghi, S
    Maffi, P
    Scirpoli, M
    Bertuzzi, F
    Pozza, G
    Secchi, A
    Bonifacio, E
    [J]. DIABETES, 2001, 50 (11) : 2464 - 2471
  • [3] PROTEIN GLYCOSYLATION AND AUTOANTIBODY RECOGNITION OF AN ISLET-CELL ANTIGEN IN TYPE-1 DIABETES
    CHRISTIE, MR
    [J]. DIABETOLOGIA, 1993, 36 : A25 - A25
  • [4] Islet autoantibody response induced by islet allotransplantation in patients with type 1 diabetes
    Braghi, S
    Maffi, P
    Bertuzzi, F
    Monti, LD
    Secchi, A
    Pozza, G
    Bonifacio, E
    Bosi, E
    [J]. DIABETES, 2000, 49 : A87 - +
  • [5] An audit of islet cell autoantibody testing for type 1 diabetes
    Courtney, C.
    Mohamed, N.
    Weston, P. J.
    [J]. DIABETIC MEDICINE, 2021, 38
  • [6] Islet autoantibody frequency in relatives of children with type 1 diabetes who have a type 2 diabetes diagnosis
    Lewis, Shanice J.
    Williams, Claire L.
    Mortimer, Georgina L.
    AWAF, Richard A.
    BOX Study Grp, William A.
    Oram, Richard A.
    Hagopian, William A.
    Gillespie, Kathleen M.
    Long, Anna E.
    [J]. DIABETIC MEDICINE, 2024, 41 (09)
  • [7] Combined use of autoantibodies (IA-2) autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes - Combinatorial Islet Autoantibody Workshop
    Verge, CF
    Stenger, D
    Bonifacio, E
    Colman, PG
    Pilcher, C
    Bingley, PJ
    Eisenbarth, GS
    [J]. DIABETES, 1998, 47 (12) : 1857 - 1866
  • [8] The level of islet autoantibody predicts persistence and progression to type 1 diabetes
    Barker, J
    Eisenbarth, G
    Yu, LP
    Miao, DM
    Barriga, KY
    Rewers, M
    [J]. DIABETES, 2003, 52 : A7 - A7
  • [9] Staging and monitoring progression to type 1 diabetes with islet autoantibody characteristics
    Achenbach, P
    Warncke, K
    Reiter, J
    Williams, A
    Bingley, P
    Bonifacio, E
    Ziegler, AG
    [J]. DIABETES, 2005, 54 : A312 - A312
  • [10] Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics
    Achenbach, P
    Warncke, K
    Reiter, J
    Naserke, HE
    Williams, AJK
    Bingley, PJ
    Bonifacio, E
    Ziegler, AG
    [J]. DIABETES, 2004, 53 (02) : 384 - 392
12345